Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Ellen, Barton"'
Autor:
Susan Eggly, Lauren M. Hamel, Elisabeth Heath, Mark A. Manning, Terrance L. Albrecht, Ellen Barton, Mark Wojda, Tanina Foster, Michael Carducci, Dina Lansey, Ting Wang, Rehab Abdallah, Narineh Abrahamian, Seongho Kim, Nicole Senft, Louis A. Penner
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-12 (2017)
Abstract Background Cancer clinical trials are essential for testing new treatments and represent state-of-the-art cancer treatment, but only a small percentage of patients ever enroll in a trial. Under-enrollment is an even greater problem among min
Externí odkaz:
https://doaj.org/article/bf62ad5127d74673ac6b73f1b89d242f
Autor:
Kirsty McLennan, Ellen Barton, Christie Lang, Ian R. Adams, Gina McAllister, Martin A.M. Reijns, Kate Templeton, Ingólfur Johannessen, Alastair Leckie, Nick Gilbert
Publikováno v:
McLennan, K, Lang, C, Adams, I R, McAllister, G, Reijns, M A M, Templeton, K, Johannessen, I, Leckie, A & Gilbert, N 2022, ' User acceptability of saliva and gargle samples for identifying COVID-19 positive high-risk workers and household contacts ', Diagnostic microbiology and infectious disease, vol. 104, no. 1, 115732 . https://doi.org/10.1016/j.diagmicrobio.2022.115732
Throughout the COVID-19 pandemic nasopharyngeal or nose and/or throat swabs (NTS) have been the primary approach for collecting patient samples for the subsequent detection of viral RNA. However, this procedure, if undertaken correctly, can be unplea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85fdaef921c3a350d82233046a29d7ff
https://hdl.handle.net/20.500.11820/4ef84a53-162b-464b-a230-cca52e602e54
https://hdl.handle.net/20.500.11820/4ef84a53-162b-464b-a230-cca52e602e54
Publikováno v:
Patient Education and Counseling. 109:149
Autor:
Tanina Foster Moore, Ellen Barton, Susan Eggly, Terrance L. Albrecht, Louis A. Penner, Lauren M. Hamel
Publikováno v:
Patient Educ Couns
Objectives Question Prompt Lists (QPL) increase patient active participation in oncology interactions, but questions remain regarding how QPLs influence patient-oncologist information exchange. We examined how a QPL influenced information exchange du
Autor:
Kirsty McLennan, Ellen Barton, Christie Lang, Ian R. Adams, Gina McAllister, Martin A. M. Reijns, Kate Templeton, Ingólfur Johannessen, Alastair Leckie, Nick Gilbert
Throughout the COVID-19 pandemic nasopharyngeal or nose/throat swabs (NTS) have been the primary approach for collecting patient samples for the subsequent detection of viral RNA. However, this procedure, if undertaken correctly, can be unpleasant an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::afd04b94fc5ab49ba2e4c09d0288ee73
https://doi.org/10.1101/2022.01.28.22270033
https://doi.org/10.1101/2022.01.28.22270033
Autor:
Jeff Pruchnic, Ellen Barton, Thomas Trimble, Sarah Primeau, Hillary Weiss, Nicole Guinot Varty, Tanina Foster Moore
Publikováno v:
Journal of Writing Assessment. 14
Autor:
Ellen Barton, Richard Marback
Publikováno v:
Rhetoric of Health & Medicine. 2:233-258
Phase 1 cancer clinical trial consultations are fraught with ethical and rhetorical issues. Phase 1 trials are designed to test the toxicity, and not the efficacy, of therapeutic agents. Fewer than 5% of patients benefit from their participation in a
Publikováno v:
Journal of Business and Technical Communication. 32:154-197
Using concepts and methods from technical and professional communication and linguistics, the authors conducted an observational study of the voice of community members (CMs) in the deliberation of a behavioral institutional review board (IRB). In th
Autor:
Mark Manning, Lauren M. Hamel, Mark Wojda, Louis A. Penner, Rehab Abdallah, Susan Eggly, Michael A. Carducci, Elisabeth I. Heath, Terrance L. Albrecht, Ting Wang, Nicole Senft, Tanina Foster, Dina Lansey, Narineh Abrahamian, Seongho Kim, Ellen Barton
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-12 (2017)
BMC Cancer
BMC Cancer
Background Cancer clinical trials are essential for testing new treatments and represent state-of-the-art cancer treatment, but only a small percentage of patients ever enroll in a trial. Under-enrollment is an even greater problem among minorities,